ACIP Approves 2021 Adult and Child/ Adolescent Immunization Schedules
| Autor: | Mark S. Freedman, Henry H. Bernstein, Kevin A. Ault |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult Immunization
Adult medicine.medical_specialty Emergency Use Authorization Health (social science) Coronavirus disease 2019 (COVID-19) Adolescent Epidemiology Health Toxicology and Mutagenesis Advisory committee Advisory Committees 01 natural sciences Food and drug administration Child and adolescent 03 medical and health sciences 0302 clinical medicine Health Information Management Interim Medicine Humans Family 030212 general & internal medicine Full Report 0101 mathematics Child Immunization Schedule Vaccines business.industry 010102 general mathematics Vaccination General Medicine United States Immunization Family medicine Practice Guidelines as Topic Centers for Disease Control and Prevention U.S business |
| Zdroj: | Morbidity and Mortality Weekly Report |
| ISSN: | 1532-0650 |
| Popis: | At its October 2020 meeting, the Advisory Committee on Immunization Practices (ACIP)* approved the Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2021. After the Emergency Use Authorization of Pfizer-BioNTech COVID-19 vaccine by the Food and Drug Administration, ACIP issued an interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years at its December 12, 2020, emergency meeting (1). In addition, ACIP approved an amendment to include COVID-19 vaccine recommendations in the child and adolescent and adult immunization schedules. After Emergency Use Authorization of Moderna COVID-19 vaccine by the Food and Drug Administration, ACIP issued an interim recommendation for use of Moderna COVID-19 vaccine in persons aged ≥18 years at its December 19, 2020, emergency meeting (2). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|